Literature DB >> 16984100

Production of vascular endothelial growth factor and endothelin in the placenta and umbilical cord during normal and complicated pregnancy.

I I Krukier1, T N Pogorelova.   

Abstract

The concentrations of vascular endothelial growth factor and endothelin in the placenta progressively increased during normal pregnancy. Production of vascular endothelial growth factor and endothelin in the placenta exceeded the normal during trimester I miscarriage and trimester III premature birth accompanied by intrauterine hypoxia. The concentration of these vasoactive substances during premature birth also increased in the umbilical cord. The compensatory decrease in the concentrations of vascular endothelial growth factor and endothelin in the placenta and umbilical cord was observed during full-term pregnancy with threatened abortion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16984100     DOI: 10.1007/s10517-006-0131-2

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  4 in total

1.  Blockade of endothelin-1 with a novel series of 1,3,6-trisubstituted-2-carboxy-quinol-4-ones controls infection-associated preterm birth.

Authors:  Nicole S Olgun; Hardik J Patel; Ralph Stephani; Istvan Lengyel; Sandra E Reznik
Journal:  Am J Pathol       Date:  2010-08-27       Impact factor: 4.307

2.  Vascular endothelial growth factor in monochorionic twins with twin-twin transfusion syndrome.

Authors:  M Morine; T Nobunaga; T Mizutani; K Yamanaka; K Wasada; K Maeda; N Suehara; T Yasui; M Irahara
Journal:  J Endocrinol Invest       Date:  2008-11       Impact factor: 4.256

3.  Dysregulation of inflammatory cytokines and inhibition of VEGFA in the human umbilical cord are associated with negative pregnancy outcomes.

Authors:  Camron Chehroudi; Hugh Kim; Tricia E Wright; Abby C Collier
Journal:  Placenta       Date:  2019-09-03       Impact factor: 3.481

4.  Placental Decidual Arteriopathy and Vascular Endothelial Growth Factor A Expression Among Women With or Without Human Immunodeficiency Virus.

Authors:  Lisa M Bebell; Kalynn Parks; Mylinh H Le; Joseph Ngonzi; Julian Adong; Adeline A Boatin; Ingrid V Bassett; Mark J Siedner; Alison D Gernand; Drucilla J Roberts
Journal:  J Infect Dis       Date:  2021-12-08       Impact factor: 5.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.